Search Results - "Teichert, Marcel"

How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective by Siefen, Ann-Cathrine, Kurte, Melina Sophie, Jakobs, Florian, Teichert, Marcel, von Tresckow, Bastian, Reinhardt, Hans Christian, Holtick, Udo, Atta, Johannes, Jehn, Christian, Sala, Elisa, Warnecke, Anke, Hänel, Mathias, Scheid, Christof, Kron, Florian

“…Treatment with chimeric antigen receptor T (CAR-T) cells involves a large number of interdisciplinary stakeholders and is associated with complex processes…”
Get full text

Outcome Prediction in Patients With Large B‐cell Lymphoma Undergoing Chimeric Antigen Receptor T‐cell Therapy by Voltin, Conrad‐Amadeus, Gödel, Philipp, Beckmann, Laura, Heger, Jan‐Michel, Kobe, Carsten, Kutsch, Nadine, Borchmann, Peter, Dietlein, Markus, Herrmann, Ken, Stelljes, Matthias, Rahbar, Kambiz, Lenz, Georg, Reinhardt, H. Christian, Teichert, Marcel, Noppeney, Richard, Albring, Jörn C., Seifert, Robert, Tresckow, Bastian, Flossdorf, Sarah, Hanoun, Christine

“…The introduction of chimeric antigen receptor (CAR) T‐cell therapy has led to a fundamental shift in the management of relapsed and refractory large B‐cell…”
Get full text

Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy by Fan, Jiaqi, Adams, Anne, Sieg, Noëlle, Heger, Jan-Michel, Gödel, Philipp, Kutsch, Nadine, Kaul, David, Teichert, Marcel, von Tresckow, Bastian, Bücklein, Veit, Goesmann, Gretha, Li, Minglun, Struve, Nathalie, Trommer, Maike, Linde, Philipp, Rosenbrock, Johannes, Celik, Eren, Penack, Olaf, Stuschke, Martin, Subklewe, Marion, Belka, Claus, von Bergwelt-Baildon, Michael, Borchmann, Peter, Marnitz, Simone, Baues, Christian

“…[Display omitted] •Radiotherapy in the context of CAR T-cell therapy may support the local disease control without increased toxicity. The neurotoxicity of CAR…”
Get full text

P-056 Bispecific Antibodies Improve Outcomes in Patients With Relapsed or Refractory Multiple Myeloma After Car-T Cell Therapy by Merz, Maximilan, Dima, Danai, Hashmi, Hamza, Mueller, Fabian, Ahmed, Nausheen, Rathje, Kristin, Davis, James, Holderried, Tobias, Vucinik, Vladan, Kharbouti, Soraya, Ayuk, Francis, Stoelzel, Friedrich, Schub, Natalie, Schmitz, Friederike, Shune, Leyla, Khouri, Jack, Anwer, Faiz, McGuirk, Joseph, Teichert, Marcel, Tresckow, Bastian von, Kroeger, Nicolaus, Pabst, Thomas, Abdallah, Al-Ola, Gagelmann, Nico

Get full text